Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome.
Gioia ColafigliEmilia ScalzulliMarika PorrazzoDaniela DiverioMaria Giovanna LoglisciRoberto LatagliataAnna GuariniRobin FoàMassimo BrecciaPublished in: Hematological oncology (2019)